Total Payments
$79,210
2024 Payments
$49,005
Companies
6
Transactions
79
Medicare Patients
438
Medicare Billing
$108,641
Payment Breakdown by Category
Other$74,140 (93.6%)
Food & Beverage$2,766 (3.5%)
Travel$2,130 (2.7%)
Education$174.84 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $74,140 | 28 | 93.6% |
| Food and Beverage | $2,766 | 37 | 3.5% |
| Travel and Lodging | $2,130 | 11 | 2.7% |
| Education | $174.84 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $78,552 | 66 | $0 (2024) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $250.49 | 4 | $0 (2019) |
| Alkermes, Inc. | $145.01 | 2 | $0 (2021) |
| Neurocrine Biosciences, Inc. | $141.86 | 1 | $0 (2024) |
| Indivior Inc. | $105.71 | 5 | $0 (2024) |
| Mallinckrodt LLC | $15.33 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $49,005 | 39 | Teva Pharmaceuticals USA, Inc. ($48,818) |
| 2023 | $29,496 | 29 | Teva Pharmaceuticals USA, Inc. ($29,478) |
| 2022 | $280.19 | 3 | Teva Pharmaceuticals USA, Inc. ($255.79) |
| 2021 | $145.01 | 2 | Alkermes, Inc. ($145.01) |
| 2019 | $268.51 | 5 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($250.49) |
| 2018 | $15.33 | 1 | Mallinckrodt LLC ($15.33) |
All Payment Transactions
79 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/11/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,080.00 | General |
| Category: Neurology | ||||||
| 10/10/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Central Nervous System | ||||||
| 09/27/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,600.00 | General |
| Category: Neurology | ||||||
| 09/20/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,600.00 | General |
| Category: Neurology | ||||||
| 09/20/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Neurology | ||||||
| 09/13/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,600.00 | General |
| Category: Neurology | ||||||
| 09/13/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $89.81 | General |
| Category: Neurology | ||||||
| 08/30/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,600.00 | General |
| Category: Neurology | ||||||
| 08/23/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,600.00 | General |
| Category: Neurology | ||||||
| 05/30/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,600.00 | General |
| Category: Neurology | ||||||
| 05/22/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,600.00 | General |
| Category: Neurology | ||||||
| 05/16/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,600.00 | General |
| Category: Neurology | ||||||
| 05/09/2024 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $28.58 | General |
| Category: BH | ||||||
| 04/29/2024 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $106.50 | General |
| 04/28/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,600.00 | General |
| Category: Neurology | ||||||
| 04/28/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $133.00 | General |
| Category: Neurology | ||||||
| 04/25/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,600.00 | General |
| Category: Neurology | ||||||
| 04/25/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $121.54 | General |
| Category: Neurology | ||||||
| 04/23/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $141.86 | General |
| Category: Neuropsychiatry | ||||||
| 04/19/2024 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: BH | ||||||
| 04/15/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,600.00 | General |
| Category: Neurology | ||||||
| 03/26/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,600.00 | General |
| Category: Neurology | ||||||
| 03/08/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,600.00 | General |
| Category: Neurology | ||||||
| 03/07/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,600.00 | General |
| Category: Neurology | ||||||
| 03/07/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 199 | 668 | $334,500 | $66,789 |
| 2022 | 3 | 189 | 470 | $206,035 | $35,051 |
| 2021 | 2 | 50 | 105 | $27,150 | $6,801 |
Total Patients
438
Total Services
1,243
Medicare Billing
$108,641
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 153 | 552 | $276,000 | $52,287 | 18.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 15 | 85 | $42,500 | $9,390 | 22.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 31 | 31 | $16,000 | $5,113 | 32.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 102 | 252 | $116,675 | $19,546 | 16.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 55 | 186 | $63,210 | $10,561 | 16.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 32 | 32 | $26,150 | $4,944 | 18.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 30 | 69 | $17,250 | $3,887 | 22.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 20 | 36 | $9,900 | $2,914 | 29.4% |
About Dr. Deepak Rajpoot, MD
Dr. Deepak Rajpoot, MD is a Child & Adolescent Psychiatry healthcare provider based in Riverside, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/18/2009. The National Provider Identifier (NPI) number assigned to this provider is 1093942864.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Deepak Rajpoot, MD has received a total of $79,210 in payments from pharmaceutical and medical device companies, with $49,005 received in 2024. These payments were reported across 79 transactions from 6 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($74,140).
As a Medicare-enrolled provider, Rajpoot has provided services to 438 Medicare beneficiaries, totaling 1,243 services with total Medicare billing of $108,641. Data is available for 3 years (2021–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Child & Adolescent Psychiatry
- Other Specialties Psychiatry
- Location Riverside, CA
- Active Since 06/18/2009
- Last Updated 02/15/2024
- Taxonomy Code 2084P0804X
- Entity Type Individual
- NPI Number 1093942864
Products in Payments
- UZEDY (Drug) $78,064
- AUSTEDO (Drug) $255.79
- ABILIFY MAINTENA (Drug) $250.49
- ARISTADA (Drug) $145.01
- INGREZZA (Drug) $141.86
- Austedo XR (Drug) $125.00
- PERSERIS (Drug) $105.71
- ACTHAR (Biological) $15.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Child & Adolescent Psychiatry Doctors in Riverside
Bipin Patel, M.d, M.D
Child & Adolescent Psychiatry — Payments: $1,440
Child & Adolescent Psychiatry $1,440
Dr. Miriam Staub, M.d, M.D
Child & Adolescent Psychiatry — Payments: $1,308
Child & Adolescent Psychiatry $1,308
John Lindo, Md, MD
Child & Adolescent Psychiatry — Payments: $790.76
Child & Adolescent Psychiatry $790.76
Dr. Shivana Naidoo, M.d, M.D
Child & Adolescent Psychiatry — Payments: $562.55
Child & Adolescent Psychiatry $562.55
Gregory Stiener, Md, MD
Child & Adolescent Psychiatry — Payments: $459.56
Child & Adolescent Psychiatry $459.56
Dr. Dalia Balsamo, M.d, M.D
Child & Adolescent Psychiatry — Payments: $367.71
Child & Adolescent Psychiatry $367.71